OpenURL Connection Search

Select item for more details and to access through your institution.

A prospective analysis of imatinib-induced c-kit modulation in ovarian cancer: A phase II clinical study with proteomic profiling.
Published in:
Cancer (0008543X), 2007, v. 110, n. 2, p. 309, doi. 10.1002/cncr.22757
By:
- Edwin M. Posadas;
- Virginia Kwitkowski;
- Herbert L. Kotz;
- Virginia Espina;
- Lori Minasian;
- Nana Tchabo;
- Ahalya Premkumar;
- Mahrukh M. Hussain;
- Richard Chang;
- Seth M. Steinberg;
- Elise C. Kohn
Publication type:
Article
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer.
Published in:
2007
By:
- Posadas, Edwin M;
- Liel, Meghan S;
- Kwitkowski, Virginia;
- Minasian, Lori;
- Godwin, Andrew K;
- Hussain, Mahrukh M;
- Espina, Virginia;
- Wood, Bradford J;
- Steinberg, Seth M;
- Kohn, Elise C
Publication type:
journal article
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancerThis is a US government work and, as such, is in the public domain in the United States of America.
Published in:
Cancer (0008543X), 2007, v. 109, n. 7, p. 1323, doi. 10.1002/cncr.22545
By:
- Edwin M. Posadas;
- Meghan S. Liel;
- Virginia Kwitkowski;
- Lori Minasian;
- Andrew K. Godwin;
- Mahrukh M. Hussain;
- Virginia Espina;
- Bradford J. Wood;
- Seth M. Steinberg;
- Elise C. Kohn
Publication type:
Article
U.S. Food and Drug Administration approval summary: Eltrombopag for the treatment of pediatric patients with chronic immune (idiopathic) thrombocytopenia.
Published in:
2017
By:
- Ehrlich, Lori A.;
- Kwitkowski, Virginia E.;
- Reaman, Gregory;
- Ko, Chia‐Wen;
- Nie, Lei;
- Pazdur, Richard;
- Farrell, Ann T.
Publication type:
journal article
Pain palliation measurement in cancer clinical trials: The US Food and Drug Administration perspective.
Published in:
Cancer (0008543X), 2014, v. 120, n. 5, p. 761, doi. 10.1002/cncr.28470
By:
- Basch, Ethan;
- Trentacosti, Ann Marie;
- Burke, Laurie B.;
- Kwitkowski, Virginia;
- Kane, Robert C.;
- Autio, Karen A.;
- Papadopoulos, Elektra;
- Stansbury, James P.;
- Kluetz, Paul G.;
- Smith, Harry;
- Justice, Robert;
- Pazdur, Richard
Publication type:
Article
FDA Approval Summary: Vemurafenib for the Treatment of Patients with Erdheim‐Chester Disease with the BRAFV600 Mutation.
Published in:
Oncologist, 2018, v. 23, n. 12, p. 1520, doi. 10.1634/theoncologist.2018-0295
By:
- Oneal, Patricia A.;
- Kwitkowski, Virginia;
- Luo, Lola;
- Shen, Yuan Li;
- Subramaniam, Sriram;
- Shord, Stacy;
- Goldberg, Kirsten B.;
- McKee, Amy E.;
- Kaminskas, Edvardas;
- Farrell, Ann;
- Pazdur, Richard
Publication type:
Article
U.S. Food and Drug Administration Approval Summary: Omacetaxine Mepesuccinate as Treatment for Chronic Myeloid Leukemia.
Published in:
Oncologist, 2014, v. 19, n. 1, p. 94, doi. 10.1634/theoncologist.2013-0077
By:
- Alvandi, Firoozeh;
- Kwitkowski, Virginia E.;
- Ko, Chia‐Wen;
- Rothmann, Mark D.;
- Ricci, Stacey;
- Saber, Haleh;
- Ghosh, Debasis;
- Brown, Janice;
- Pfeiler, Erika;
- Chikhale, Elsbeth;
- Grillo, Joseph;
- Bullock, Julie;
- Kane, Robert;
- Kaminskas, Edvardas;
- Farrell, Ann T.;
- Pazdur, Richard
Publication type:
Article
FDA review summary of patient-reported outcome results for ibrutinib in the treatment of chronic graft versus host disease.
Published in:
2020
By:
- King-Kallimanis, Bellinda L.;
- Wroblewski, Tanya;
- Kwitkowski, Virginia;
- De Claro, R. Angelo;
- Gwise, Thomas;
- Bhatnagar, Vishal;
- Farrell, Ann T.;
- Kluetz, Paul G.
Publication type:
journal article
Commentary on Heath et al.
Published in:
Clinical Trials, 2017, v. 14, n. 6, p. 572, doi. 10.1177/1740774517723308
By:
- Kwitkowski, Virginia;
- Daniels, Selena;
- Reaman, Gregory;
- Farrell, Ann;
- Kluetz, Paul
Publication type:
Article

Found: 9